摘要
准确判断膀胱癌预后对治疗有重要意义 ,近年来飞速发展的分子生物学对确定膀胱癌的恶性程度及预后有重要价值。本文主要介绍一些相关性较强标记物 ,以期能找到评价膀胱癌预后更敏感、特异、实用的肿瘤标记物。
出处
《国外医学（泌尿系统分册）》
2003年第6期625-630,共6页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献29
-
1Korkolopoulou P, Konstantinidou AE, Thomas-Tsagli E, et al. Appl Immunohistochem Mol Morphol,2000;8.285 ～ 292.
-
2Stein JP, Ginsberg DA, Grossfeld GD, et el.J Natl Cancer Inst, 1998;90:1072 ～ 1079.
-
3Furukawa A,Tsuji M, Nishitani M,et al.Urology, 1998 ; 51: 84.9 ～ 853.
-
4Kanayama H, Yokota K,Kurokawa Y,et al.Cancer, 1998; 82:1359 ～1366.
-
5Gohji K,Fujimoto N,Ohkawa J,et al.Br J Cancer,1998;77:650 ～ 655.
-
6Hara I,Miyske N,Hara S, et al.J Urol.,2001; 165:1769 ～ 1772.
-
7Akira Y,Takahisa N,Kunihiro H,et al.J Urol,2002; 167:729 ～ 734.
-
8Durkan GC, Nutt JE,et al.Clin cancer Res,2001 ;7:3450～ 3456.
-
9Miyanaga N,.Akaza H,Ishikawa S,et al.Eur Urol, 1997;31:163 ～ 168.
-
10Soloway MS, Brisgnan V, Carpinito GA, et al.J Urol, 1996; 156:363～367.
同被引文献6
-
1Soker S,akashima S,iao HQ,t al .Neuropilin is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor[J].Cell,1998;92:735-45.
-
2Lu D,imenez X,hang H,t al .Selecting of high affinity human neutralizing antibodies to VEGF2/KDR from a large antibody phage display library for antiangiogenesis therapy[J].Int J Cancer,2002;97:393-9.
-
3Meyer T,art IR.Mechanism of tumor metastasis[J].Eur J Cancer,1998;34(2):214-221.
-
4Santos L,osta C,ereira S,t al .Neovascularisation is a prognosticfactor of early recurrence in T1/G2 urothelial bladder tumor[J].Ann Oncol,2003;14(9):1419-24.
-
5Bellmunt J,ussain M,inney CP.Novel approaches with targeted therapies in bladder cancer.Therapy of bladder cancer by block of the epidermal growth factor receptor family[J].Crit Rev Oncol Hematol,2004;46(Suppl):85-104.
-
6Suhardja A,offman H.Role of growth factor and their receptors in proliferation of microvascular endothelial cells[J].Microsc Res Tech,2003;60:70-5.
-
1余文（摘译）.胃癌患者血管内皮生长因子可作为胃癌患者的预后标记物[J].中华医学信息导报,2011,26(4):10-10. 被引量：2
-
2陈嫣,王静,王子毅,许一诺,洪婷.宫颈腺癌的诊治及研究进展[J].肿瘤药学,2016,6(5):326-332. 被引量：6
-
3王宏坤,梁建芳,郑绘霞,程彩霞,李宁,肖虹.nm23-H1——胃肠道间质瘤新的预后标记物[J].中国药物与临床,2008,8(2):88-90.
-
4傅德良.胰腺导管癌切除标本中的p16^(INK4a)是一预后标记物[J].国外医学（外科学分册）,2002,29(4):249-250.
-
5高琨,刘静贤,刘毅强,陈柯.食管鳞癌与p53及CD44v6表达分析[J].肿瘤防治研究,2003,30(2):115-116. 被引量：2
-
6蔡永林,王伟,周玲.鼻咽癌转移及预后分子标志物[J].分子诊断与治疗杂志,2012,4(2):137-141. 被引量：4
-
7赵兵,杨顺娥.弥漫大B细胞淋巴瘤预后标记物的研究进展[J].新疆医科大学学报,2009,32(8):1040-1042.
-
8刘春玲,何晖,刘再毅,张水兴,梁长虹.ADC值与乳腺浸润性导管癌预后标记物间相关性的探讨[J].临床放射学杂志,2014,33(2):194-198. 被引量：13
-
9朱明华.胰腺癌病理学及分子病理学的研究进展[J].第二军医大学学报,2005,26(10):1085-1087.
-
10魏瑜,张莉.PD-L1表达与食管癌预后相关性的Meta分析[J].现代肿瘤医学,2017,25(1):48-51. 被引量：3
